Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
The Journal of Infectious Diseases|March 15, 2021
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 VaccineKening Wang, Lesia Dropulic, Joel Bozekowski, et al.
The Journal of Infectious Diseases|May 10, 2020
Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 PathwaysMatthew K Howe, Kennichi Dowdell, Hye Sun Kuehn, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus VaccineAlexander C Vostal, Dawid Maciorowski, James M Readler, et al.
Blood|June 4, 2021
CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytesJulie Brault, Taylor Liu, Ezekiel Bello, et al.
Research Square|October 4, 2023
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesUrsula Buchholz, Jaclyn Kaiser, Christine Nelson, et al.
Blood|May 9, 2019
Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whitesJeffrey I Cohen, Irini Manoli, Kennichi Dowdell, et al.
Nature Communications|April 26, 2024
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesJaclyn A Kaiser, Christine E Nelson, Xueqiao Liu, et al.
Pageof 2